IWIN — Irwin Naturals Share News
0.000.00%
HealthcareSpeculativeMicro Cap
Brief: Irwin Naturals Q3 Adjusted EBITDA USD -1.651 Million
Brief: Repeat - Irwin Naturals Acquires Ketamine Media
Brief: Irwin Naturals Terminates Letter Of Intent For Business Combination With Braxia Scientific
Brief: Irwin Naturals Secures $40 Mln Financing For Its Current Operations
Brief: Irwin Naturals Files Q2 2022 Financials
Brief: Entourage Health Signs Exclusive Licensing Agreement With Irwin Naturals To Produce And Distribute Its Cannabis Products In Canada
Brief: Datinvest, GVB Biopharma And Irwin Naturals Enter Into Letter Of Intent For A Business Combination